SAB Biotherapeutics, Inc.

Home - SAB BIO

Sioux Falls, United States · Founded 2016 · $133.9M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$133.9M
Last Round
$130.0M Growth EquityOct 2023
Rounds
4

About

SAB Biotherapeutics is a clinical-stage biopharmaceutical company developing disease-modifying immunotherapies for autoimmune diseases. Its lead asset, SAB-142, targets Type 1 Diabetes by addressing the underlying autoimmune cause — preserving beta cell function rather than managing symptoms. Founded in 2016 in Sioux Falls, South Dakota, SAB has received SBIR/STTR awards from the Department of Health and Human Services.

Summary

SAB Biotherapeutics, Inc. is a Biotech company based in Sioux Falls, United States, founded in 2016. It has raised $133.9M in total across 4 rounds, most recently a $130.0M Growth Equity round in Oct 2023. Investors include Sanofi Ventures, RA Capital Management and Commodore Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityOct 2023
$130.0M

Sign up to see all 4 rounds

Grant through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SAB Biotherapeutics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/sab-biotherapeutics-inc"><img src="https://indexed.vc/api/badge/company/sab-biotherapeutics-inc" alt="SAB Biotherapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>